药物组合的分子复合物:对共晶体,盐,共形系统和无形固体分散物的综述
Jinghan Li1, Xiyan Wang2, Dongyue Yu3
1Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
固定剂量组合 (FDC) 在治疗癌症等疾病方面至关重要. 本综述探讨了药物-药物分子复合物,包括共晶和盐,以改善疗法和患者遵守.
科学领域:
- 制药科学 制药科学
- 药用化学 医学化学
- 药物运输 药物运输 药物运输
背景情况:
- 组合疗法对于治疗癌症,心血管和传染病等复杂疾病至关重要.
- 固定剂量组合 (FDCs) 旨在减少药物负担并提高患者的遵守性.
- 药物-药物分子复合体在FDC中代表了一种有效的方法,其中有几个被监管机构批准.
研究的目的:
- 提供药物药物分子复合物的综合性审查,作为治疗策略.
- 阐明涉及的分子机制,分子间相互作用和功能组.
- 讨论各种分子复杂类型的应用,优势和挑战.
主要方法:
- 文献综述专注于药物分子复合物的药物药物.
- 分子机制和分子间相互作用的分析.
- 评估共晶体,盐,共形系统和固体分散的应用,优势和挑战.
主要成果:
- 药物-药物分子复合物,包括共晶体,盐,共形系统和固体分散,提供高效的治疗解决方案.
- 了解分子间相互作用是设计有效分子复合体的关键.
- 各种类型的分子复合体已经证明了成功的临床应用和FDA批准.
结论:
- 药物分子复合体是开发先进组合疗法的有前途领域.
- 对分子机制和设计原则的洞察力可以指导新型FDC的制造.
- 未来的研究应该专注于创造新的分子复合体,使更广泛的患者群体受益.
更多相关视频
05:08Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
13:05Reliable Mechanochemistry: Protocols for Reproducible Outcomes of Neat and Liquid Assisted Ball-mill Grinding Experiments
Published on: January 23, 2018
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Complexation Equilibria: Overview
The equilibrium constant of the complexation reaction is represented as the formation constant...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Drug-Receptor Bonds
In...
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
